Friday 6 November 2026 Export RVMD’s income statement to Excel — free account

Revolution Medicines, Inc.

Revolution Medicines, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $11.6 million, down 67.3% from fiscal 2022.

Revenue: +1,188.7%
EPS: −18.0%
Free cash flow: −99.1%
Total debt: +322.7%

Quarter to September 2026, against a year earlier

192.35 14.70 +8.27%

Follow RVMD

Alert me

Market cap: $38.1B
P/E: 0.0×
Fwd P/E: −11.9×
Dividend yield: —
F-score: 4/9
Altman Z: 7.73
Beneish M: −4.29
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Revolution Medicines, Inc. (RVMD) Current ratio

Alert me on Current ratio

Revolution Medicines, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 8.4×, up 1.2× from fiscal 2025 (7.1×). Over the past ten years it has ranged from 1.2× (fiscal 2017) to 14.2× (fiscal 2024); the current reading is higher than 44% of that period. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/RVMD/current-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Revolution Medicines, Inc. current ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/RVMD/metrics/current-ratio">Revolution Medicines, Inc. (RVMD) current ratio — stockrow.com</a></p>

Period	Current ratio	Change
FY2025	7.1×	(49.68%)
FY2024	14.2×	8.70%
FY2023	13.1×	22.66%
FY2022	10.7×	8.99%
FY2021	9.8×	1.52%
FY2020	9.6×	209.31%
FY2019	3.1×	11.30%
FY2018	2.8×	125.03%
FY2017	1.2×	—

Period	Current ratio	Change
Sep 2026	8.4×	(26.52%)
Jun 2026	11.4×	67.43%
Mar 2026	6.8×	(4.89%)
Dec 2025	7.1×	(11.25%)
25 more quarters	Free account

Against its own ten years

Low 1.2× High 14.2×

Ten-year median 9.6×

Current reading's percentile 44

Company	Current ratio
ROIV Roivant Sciences Ltd. compare	16.7×
BNTX BioNTech SE Sponsored ADR compare	8.6×
RVMD Revolution Medicines, Inc.	8.4×
ARGX argenex SE compare	5.1×
INCY Incyte Corporation compare	3.8×
ONC BeOne Medicines Ltd. - Sponsored ADR compare	3.6×
INSM Insmed, Inc. compare	2.9×
GMAB Genmab A/S Sponsored ADR compare	2.5×
RPRX Royalty Pharma PLC compare	1.3×
Biotechnology industry median	4.9×
Healthcare sector median	3.1×
Market median	1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

Revolution Medicines, Inc. (RVMD) Current ratio

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on RVMD

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on RVMD

Stockrow Weekly